- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE and Surgi-Vision sign marketing agreement
General Electric Medical Systems has entered into a marketing and distribution agreement with Surgi-Vision, a manufacturer of specialized MR coils used to take images from inside the body. Last year, Surgi-Vision received 510(k) clearance from the Food
General Electric Medical Systems has entered into a marketing and distribution agreement with Surgi-Vision, a manufacturer of specialized MR coils used to take images from inside the body. Last year, Surgi-Vision received 510(k) clearance from the Food and Drug Administration for clinical use of a new coil to image the esophagus and aorta. The coil will be distributed exclusively with the GE Signa CV/I MRI scanner, which images the heart and blood vessels.
Future products from Surgi-Vision will provide high-resolution images of the heart, urethra, and prostate. The new technology for the coils was developed at the Johns Hopkins University Department of Radiology. Doctors will now be able to explore intravascular plaques through the use of MR technology in a noninvasive procedure, said Dennis Cooke, global general manager of GEs MR business.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
